Recombinant Mouse Asprosin (N-8His)

Item number: EPT137
Availability: In Stock
$819.00
$819.00
Please hurry! Only 100 left in stock

Documents

Size: 50ug
Subtotal: $819.00
10 customers are viewing this product

Customized & fast shipping

Terms and Conditions

Recombinant Mouse Asprosin (N-8His)

Recombinant Mouse Asprosin (N-8His)

$819.00

Recombinant Mouse Asprosin (N-8His)

$819.00
Size: 50ug
Description
Recombinant Mouse Fibrillin-1 is produced by our Mammalian expression system and the target gene encoding Ser2734-His2873 is expressed with a 8His tag at the N-terminus.
Accession
AAA56840.1
Molecular weight
16.9 KDa
Apparent molecular weight
30 KDa, reducing conditions
Other names
Fibrillin-1; Fbn1; Asprosin; Fbn-1
Purity
Greater than 85% as determined by reducing SDS-PAGE.
Endotoxin
Less than 0.1 ng/µg (1 EU/µg) as determined by LAL test.
Redissolve
Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles.
Storage
Lyophilized protein should be stored at < -20°C, though stable at room temperature for 3 weeks. Reconstituted protein solution can be stored at 4-7°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months.
Delivery condition
The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature listed below.
Asprosin is a protein hormone that is produced by white adipose tissue in mammals (and potentially by other tissues), which is then transported to the liver and stimulates it to release glucose into the blood stream. In the liver asprosin activates rapid glucose release by a cAMP-dependent pathway. The glucose release by the liver into the blood stream is vital for brain function and survival during fasting. People with neonatal progeroid syndrome lack asprosin, while people with insulin resistance have it in abundance. In animal tests asprosin showed potential for treating type 2 diabetes. When antibodies targeting asprosin were injected into diabetic mice, blood glucose and insulin levels improved.

Related Products

Recently Viewed Products